Related Experiment Video
Updated: Dec 31, 2025

06:00
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024
1.9K
Finding small molecules with pan-serotype activity to target Dengue non-structural protein 1
Bibhudutta Mishra1, Raaghavi Raghuraman1, Arjun Agarwal2
11Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, K K Birla Goa Campus, Zuarinagar, South Goa, Goa 403 726 India.
Virusdisease
|January 1, 2020
Summary
Researchers identified plant flavonoids as potential drugs targeting Dengue virus (DENV) non-structural protein 1 (NS1) across all four serotypes. This study offers a novel therapeutic strategy for Dengue fever and severe Dengue.
Area of Science:
- Virology
- Drug Discovery
- Structural Biology
Background:
- Dengue virus (DENV), a mosquito-borne flavivirus, causes Dengue fever and severe Dengue.
- DENV has four serotypes, each with varying pathogenicity and genotypes.
- The DENV non-structural protein 1 (NS1) is crucial for viral replication and pathogenesis, and serves as a diagnostic marker.
Purpose of the Study:
- To explore small molecule drugs targeting the NS1 protein of all four DENV serotypes.
- To identify common plant flavonoids with high binding affinities to DENV NS1 across serotypes.
Main Methods:
- Modeled NS1 structures for DENV serotypes 1, 3, and 4 based on the DENV 2 NS1 crystal structure.
- Performed virtual screening of plant flavonoids against DENV NS1 active sites.
- Analyzed top-scoring molecules for commonality and comparable binding affinities across all four serotypes.
- Conducted ADMET profiling on promising flavonoid candidates.
Main Results:
- Identified potential plant flavonoids that bind to the NS1 protein of all four DENV serotypes.
- Selected common flavonoids with comparable binding affinities across serotypes.
- Filtered candidates using ADMET profiling for drug-likeness.
Conclusions:
- Plant flavonoids show promise as broad-spectrum therapeutic agents against DENV NS1.
- This research provides a foundation for developing novel anti-DENV drugs targeting NS1.
- Further studies are warranted to validate these findings and advance drug development.

